Robert Heine to Cost-Benefit Analysis
This is a "connection" page, showing publications Robert Heine has written about Cost-Benefit Analysis.
Connection Strength
0.039
-
Lim SL, Havrilesky LJ, Heine RP, Dotters-Katz S. The cost-effectiveness of ertapenem for the treatment of chorioamnionitis after cesarean delivery. J Matern Fetal Neonatal Med. 2020 Dec; 33(24):4096-4101.
Score: 0.039